Chemoradiotherapy is Associated with Improved Survival for Resected Pancreatic Adenosquamous Carcinoma: An analysis from the SEER database

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024523

Enrollment

Unknown

Registered

2019-07-13

Start date

2019-07-12

Completion date

Unknown

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Adenosquamous Carcinoma

Interventions

Case series:No intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients data retrieved from the Surveillance, Epidemiology, and End Results database (SEER) were analyzed in this study.The following criteria were : all patients were diagnosed as PASC (ICD-O-3: 8560/3) with surgical resection, along with explicit data about gender, age, primary site, grade, T staging, N staging, M staging, postoperative chemotherapy, radiotherapy, number of concomitant tumors and survival information.

Exclusion criteria

Exclusion criteria: patients with unknown demographic, operative or histopathological details, or lack of survival information were excluded in our study.

Design outcomes

Primary

Measure	Time frame
overll survival;	—

Countries

China

Contacts

Public ContactWenhui Lou

Zhongshan Hospital, Fudan University

louzsh@126.com+86 13681971683

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026